Menu
  • Join
  • Login
  • Contact
 

Search abstracts / presentations


Factors affecting clopidogrel safety in the montenegrin population

  • At: Seville (Spain) (2022)
  • Type: Poster
  • Poster code: PPM-004
  • By: MUGOšA, Snežana (Institute For Medicines And Medical Devices Of Montenegro, Montenegro)
  • Co-author(s): Dr Snežana Mugoša, Managing Director (Institute For Medicines And Medical Devices Of Montenegro, Podgorica, Montenegro)
    Anja Glušica, Centre for medicines quality, safety and efficacy assessment (Institute For Medicines And Medical Devices Of Montenegro, Podgorica, Montenegro)
    Jelena Rakočević, Centre for medicines quality, safety and efficacy assessment (Institute For Medicines And Medical Devices Of Montenegro, Podgorica, Montenegro)
  • Abstract:

    Background: This study addresses the genetic and non-genetic factors associated with increased risk of having major adverse cardiac events in Montenegrians treated with clopidogrel.
    Objectives: The aim of this study was to provide the analysis of genetic and non-genetic factors that influence clopidogrel safety in cardiology patients.
    Methods: We..

  • The access to the whole abstract and if available the presentation file is available to FIP members and to congress participants of that specific congress. Please login
Last update 28 September 2023

FIP Congresses